Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Accounts Payable : HK$5,832 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Accounts Payable?

Shanghai Fosun Pharmaceutical (Group) Co's Accounts Payable for the quarter that ended in Mar. 2025 was HK$5,832 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly Accounts Payable declined from Sep. 2024 (HK$6,983 Mil) to Dec. 2024 (HK$6,403 Mil) and declined from Dec. 2024 (HK$6,403 Mil) to Mar. 2025 (HK$5,832 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual Accounts Payable declined from Dec. 2022 (HK$7,017 Mil) to Dec. 2023 (HK$6,737 Mil) and declined from Dec. 2023 (HK$6,737 Mil) to Dec. 2024 (HK$6,403 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Accounts Payable Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Accounts Payable Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

3,898.91

6,200.33

7,017.48

6,737.26

6,403.24

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															6,659.90	7,025.46	6,982.90	6,403.24	5,831.59

Shanghai Fosun Pharmaceutical (Group) Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Shanghai Fosun Pharmaceutical (Group) Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Accounts Payable

Traded in Other Exchanges

SFOSF:USA 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Shanghai Fosun High Technology (group) Co., Ltd.
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2101 Beneficial owner
Guo Guangchang	2201 Interest of corporation controlled by you

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines